Document Mentions (5 shared documents)

EFTA02686169

3 mentions1 same-page

Page ?Same page

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

ive Officer Estee Lauder Companies USA Inc. Andy Freire Chairman Endeavor Argentina Julio Frenk Dean Harvard School of Public USA Health Jacob A. Frenkel Chairman JPMorgan Chase JPMorgan Chase & Co. USA International Rainer-Marc Frey Chairman of the Board of Directors Horizon21 AG Switzerland

EFTA02686246

3 mentions1 same-page

Page ?Same page

Chief Executive Officer Metabolix USA David R. Epstein Head. Pharma Division Novartis AG Switzerland

rman of the Board OBO Bettermann Group Germany Jeffrey L. Bewkes Chairman and Chief Executive Officer

EFTA02407985

2 mentions1 same-page

Page ?Same page

To: Undisclosed recipients:[@] From: Jeffrey M Matusow Sent: Fri 8/13/2010 12:40:17 PM Subj

onment. To help make sense of the changing landscape, we are pleased to invite you to a special conference call on Sept. 1 at 11 a.m. (ET) with Dr. Jacob A. Frenkel, Chairman of JPMorgan Chase International. Dr. Frenkel will be attending this private symposium and will share his insights on the topics that were